Unicycive Therapeutics, Inc.
NASDAQ:UNCYBiotechnology
-$0.24 today
- Market cap
- $103.02M
- Beta
- 1.73
- P/E (TTM)
- -40.8
- EPS (TTM)
- -$0.17
Volume 0.86M
Average 0.65M
Balance Sheet
Inspect the capital base behind the business.
Assets
$49.13M
FY 2025 · Annual
+55.2% YoYLiabilities
$18.94M
FY 2025 · Annual
-21.9% YoYEquity
$30.20M
FY 2025 · Annual
+306.4% YoYBalance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $37.4M |
| Short-term Investments | $17.2M |
| Other Current | $9.0M |
| Total Current Assets | $63.5M |
| PP&E (Net) | $861.0K |
| Total Non-current Assets | $861.0K |
| Total Assets | $64.4M |
Analysis
Selected assets total $64.4M for Latest. The largest visible component is Cash & Equivalents at $37.4M, about 58.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Oct 29, 2026 | |
| 3 | Initial statement of beneficial ownership | Oct 1, 2026 | |
| 8-K | Current report | Sep 29, 2026 | |
| 8-K | Current report | Sep 28, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 |
How much cash does UNCY have?
Unicycive Therapeutics, Inc. (UNCY) reported $29.20M in cash and equivalents in fiscal 2025.
How much debt does UNCY carry?
Unicycive Therapeutics, Inc. (UNCY) reported $199,000.00 of total debt, with net debt of -$29.00M.
Continue the stock analysis
Jump to another research area for this company.